Tao Wei

机构：Shihezi University, Brigham and Women's Hospital, Memorial Sloan Kettering Cancer Center, Harvard University, Wenzhou University, Army Medical University, Dalian Medical University, Sichuan University, West China Hospital of Sichuan University, Eye & ENT Hospital of Fudan University, Xinqiao Hospital, Weihai Municipal Hospital, Buchang Pharma (China), Stomatological Hospital of Chongqing Medical University, First Affiliated Hospital of Shihezi University Medical College, Central Hospital of Zibo, State Key Laboratory of Biotherapy, Chongqing Medical University · ORCID：0000-0002-9993-5054

发表论文 123 篇 · 总被引 2006 次 · h-index 26

代表论文

• Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation (2025 · Cell Metabolism · 被引 54)
• A multicenter cohort study of thyroidectomy-related decision regret in patients with low-risk papillary thyroid microcarcinoma (2025 · Nature Communications · 被引 29)
• Data Interpreter: An LLM Agent for Data Science (2025 · 被引 26)
• Synergistic effects of sulfur-doped carbon dots/permanganate process for DCF degradation: Mechanism and pathways (2025 · Journal of Hazardous Materials · 被引 12)
• Global, regional, and national burden of pneumococcal disease among children and adolescents aged <20 years from 1990 to 2021: a predictive analysis (2025 · Frontiers in Public Health · 被引 5)
• Meta-analysis of the value of albumin-bilirubin grading on changes in liver function and its prognostic assessment in patients with hepatocellular carcinoma treated with transhepatic arterial chemoembolization (2025 · World Journal of Surgical Oncology · 被引 4)